Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Todisco Joseph, holds the title of Chief Executive Officer at CorMedix Inc..
On 2026-11-13, the insider transacted 80,000 shares.The shares were transacted at a weighted average price of $4.89 per share, resulting in a total market-relevant value of $391K.
Todisco Joseph (Chief Executive Officer) bought $391K of $CRMD
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.